Koss Olinger Consulting, LLC Novo Nordisk A S Transaction History

Koss Olinger Consulting, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	SELL	$103.24 - $121.81 $216,391 - $255,313	-2,096 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$93.1 - $112.54 $42,360 - $51,205	-455 Reduced 17.84%	2,096 $233,000
Q4 2021 Feb 07, 2022	SELL	$95.88 - $117.08 $29,531 - $36,060	-308 Reduced 10.77%	2,551 $286,000
Q3 2021 Nov 09, 2021	SELL	$84.42 - $106.62 $125,785 - $158,863	-1,490 Reduced 34.26%	2,859 $274,000
Q2 2021 Aug 11, 2021	BUY	$67.66 - $84.76 $30,176 - $37,802	446 Added 11.43%	4,349 $364,000
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $261,735 - $295,925	3,903 New	3,903 $263,000

1,991

318M

5.23M

4.97M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $273B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

Stay updated on Koss Olinger Consulting, LLC with notifications on news.